Stock Report: Exactech Inc. (EXAC) Report Updated: May 20, 2013 | Print This Page

Exactech, Inc. develops, manufactures, markets, distributes, and sells orthopaedic implant devices, and related surgical instrumentation and biologic services. It offers knee implants that address orthopedic surgeons’ concerns for contact stress, patellar tracking, polyethylene wear, joint stability, bone preservation, and instrumentation; and hip implants for hip arthroplasty, hip fractures, and primary hip surgery. The company also provides biologics and spine products for the healing and regeneration of bone and soft tissue; and allograft tissue implants for oral and dental applications. In addition, it offers shoulder systems for the treatment of degenerative disease and trauma; hip, knee, and shoulder spacers that are used in two stage revision procedures; and an air-driven impact handpiece that surgeons could use during joint implant revision procedures to remove failed prostheses and bone cement. The company markets its orthopedic implant products through a network of independent sales agencies, direct sales representatives, and independent distributors to hospitals, surgeons and other physicians, and clinics in the United States and internationally. It has a strategic partnership with Genzyme Biosurgery Corporation for the development of polymer-based synthetic biomaterials. The company was founded in 1985 and is based in Gainesville, Florida.